Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA Title Grant Type Focus Area Country Application Due Date Improving the Outpatient Management of Emergency Department Patients with Venous Thromboembolism (VTE)Release Date:Partner: American College of Emergency Physicians (ACEP)Quality Improvement Internal Medicine USA HER2 Expression in Urothelial Carcinoma (UC)Release Date:Education Oncology All Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital Benin, Congo, The Democratic Republic Closing the Knowledge Gap in anti-TNF Cycling in Rheumatoid ArthritisRelease Date:Education Inflammation & Immunology USA Increasing Healthcare Professional Skills For COVID-19 Vaccine Discussions That Advocate VaccinationRelease Date:Education Vaccines USA Community Oncology Support for Therapy Management in Multiple Myeloma (MM)Release Date:Education Oncology USA Management of Adults and Adolescents with Alopecia AreataRelease Date:Education Inflammation & Immunology USA Sickle Cell Disease Transition in CareRelease Date:Partner: National Alliance of Sickle Cell CentersQuality Improvement Rare Disease USA 2025 Rheumatology Fellowship – United StatesRelease Date:Fellowship Inflammation & Immunology USA Closing the Knowledge Gap in the Diagnosis and Management of Idiopathic Inflammatory Myopathies (IIM)Release Date:Education Inflammation & Immunology USA Invasive Mold Diseases (IMD) & Treatment OutcomesRelease Date:Research Hospital Australia, Austria, Belgium, China, France, Germany, Greece, Italy, Korea, Netherlands, Spain, Switzerland, United Kingdom Implementing Updated RSV Immunization Recommendations for Older AdultsRelease Date:Education Vaccines USA